Video09 Jul 2024

Future of Health: The Impact of GLP-1s on Diabetes Care

Adam Spielman, Head of Health, Citi Global Insights with Jim Hollingshead, Chief Executive Officer, Insulet, discuss GLP-1s and their impact on Diabetes Care.

Key topics:

  • In what ways are GLP-1s impacting Insulet’s business?
  • How do diabetics who use GLP-1s behave differently from non-users?
  • To what extent is Insulet changing its strategy because of GLP-1s?
  • If GLP-1s do reduce obesity long term, what impact would there be?



Sign up to receive our newsletter providing a roundup of recent content and updates on new reports.

Sign up to receive the latest news from Citi.